Medication-related osteonecrosis of the jaws (MRONJ) is a challenging situation in clinics. Previous studies have shown that pentoxifylline combined with tocopherol proved to be beneficial in patients with osteoradionecrosis, due to their antioxidant and antifibrotic properties. The aim of this randomized study was to evaluate the effect of pentoxifylline and tocopherol in patients that had developed MRONJ after tooth extractions. The study population consisted of 202 Stage I MRONJ female patients with an average age of 66.4 ± 8.3 years, who were divided into two groups. The test group (n = 108) received a pharmacological protocol with pentoxifylline and tocopherol (2 months pre-operatively and 6 months post-operatively). The control group (n = 94) had sequestrectomy operations without any pharmacological preparation. The main outcomes were clinical healing of the mucosa after 1 month, and clinical and radiographic healing of the bone lesion at 6 months. In the test group all patients had mucosal healing and there was only one relapse within 6 months. In the control group, in 17% of the patients the mucosa did not heal, 71% of the patients relapsed within two months, and 7% developed infectious complications (such as abscess or phlegmon). After 6 months, the control group patients with persisting issues were prescribed pentoxifylline and tocopherol, as in the test group. At a subsequent follow-up, all those patients healed completely. Patients were monitored for a period of 7.8 ± 0.3 years, during which no relapse or additional problems were reported. As a conclusion, pentoxifylline and tocopherol protocol seems to be beneficial in the management of MRONJ patients.
Background: To evaluate the effectiveness of hyaluronic acid (HA) gel injection with and without plasma rich in growth factors (PRGF) for the management of interdental papillary loss. Methods: A single blinded randomized clinical trial was carried out on 21 subjects with 34 sites. Patients within the age group 18–45 years who had Class I and II papillary recession in the maxillary anterior region were selected. The sites involved were randomly assigned to Group HA alone and Group HA + PRGF. The patients were recalled 4 weeks after receiving supragingival and subgingival instrumentation. HA or HA + PRGF was injected into the defective papilla at baseline and at 3 and 6 weeks. Image based measurements of Papillary Width (PW), Papillary Deficient Height (PDH), Deficient Area (DA), Deficient Volume (DV) were registered at baseline, 3 weeks, 6 weeks and 12 weeks. A vernier caliper was used to measure the papillary depth in the impression made using additional silicone impression material pre- and post-intervention. Results: There was a significant improvement in the within-group comparison of PW, PDH, DA and DV in both the groups. Group HA + PRGF showed significantly greater improvement in comparison to Group HA alone in terms of PDH, DA and DV at 6 and 12 weeks. Conclusions: Even though HA gel has already been established as a promising injectable agent in the minimally invasive treatment of interdental papillary deficiency, PRGF may also have a significant adjuvant effect when used along with HA. Further clinical studies with longer follow up duration, larger sample size and standardization of the tooth shape are required for a better understanding of the adjuvant effect of PRGF when used along with HA.
Objectives: The aim of this retrospective study was to evaluate the long-term clinical and radiographic performance of zirconia dental implants with one-piece and two-piece configurations supporting single-tooth restorations. The primary outcome was implant survival, while the secondary outcome was the assessment of interproximal marginal bone loss (MBL) over time. Materials and methods: A total of 67 implants placed in 55 patients were included, with a mean follow-up of 60.6 months. Forty-five implants were one-piece systems and twenty-two were two-piece systems. All surgical and prosthetic procedures were performed by the same operator, following the manufacturer’s recommendations. Final restorations were delivered three months after implant placement. Marginal bone levels were assessed radiographically at the time of definitive prosthesis delivery (T0) and at the last follow-up examination (T1). Statistical significance level was set at 5% (α = 0.05). Results: The overall implant survival rate was 100% in both groups. One-piece implants showed higher initial MBL values than two-piece implants; however, bone level changes over time were limited in both configurations, with no significant intra-group differences between T0 and T1. Conclusions: Both implant configurations showed excellent clinical and radiographic outcomes, with a 100% survival rate and limited marginal bone loss during long-term follow-up. Marginal bone levels appeared to be influenced more by implant neck design than by implant configuration, suggesting that zirconia implants with a smooth transmucosal design may represent a reliable metal-free option for single-tooth rehabilitation in properly selected patients.
Objectives: The aim of this in vitro study was to evaluate the accuracy of intraoral impressions obtained using the Trios 3Shape® (3Shape Trios, Copenaghen, Denmark) and Carestream CS 3600™ (Carestream Dental, Stuttgart, Germany) scanners, compared with traditional polyvinyl siloxane (PVS) impressions. A laboratory scanner served as the gold standard. Materials and Methods: The study was based on 3D-printed master models derived from partially edentulous clinical cases previously treated at our department (2017–2022). All cases required at least two implants. Data analysis was performed using one-way ANOVA and two-sample Z-tests (α = 0.05) to compare mean deviations and variability. Results: All techniques demonstrated high accuracy, with deviations from the reference point below 30 μm. The digital intraoral scanners (Trios 3Shape® and Carestream CS 3600®) showed superior accuracy compared with PVS analog impressions, with no statistically significant difference between the two IOS systems. Conclusions: Within the limitations of this in vitro study, both IOS systems and PVS analog impressions achieved clinically acceptable accuracy. Digital systems exhibited improved performance in terms of mean deviation and consistency. The higher accuracy and consistency of digital impressions may translate into improved clinical efficiency and prosthetic fit in implant rehabilitations. From a clinical perspective, these in vitro findings suggest that digital impressions may enhance prosthetic fit and workflow efficiency, though further in vivo validation is required. Clinical significance: This study supports the reliability of intraoral scanning compared with conventional impressions in implant-supported rehabilitations. By demonstrating high intrinsic accuracy, these findings contribute to optimizing digital workflows in implant dentistry and reinforce the potential of intraoral scanning in static computer-guided, flapless implant surgery. Trial registration: Ethical approval and trial registration were not applicable to the present in vitro investigation, as no patients were directly involved in the experimental phase. The digital data used to generate the laboratory master models originated from a separate clinical study conducted at ASST Santi Paolo e Carlo, Milan (Ethics Committee approval no. 1361, 12 July 2017; ClinicalTrials.gov registration, Unique Protocol ID 1361).
Objectives: This prospective cohort study aimed to evaluate the accuracy and precision of static computer-guided, flapless implant surgery in partially edentulous patients, comparing the virtually planned and clinically achieved implant positions. Materials and Methods: From 2017 to 2022, 40 patients (20 males and 20 females) received a total of 129 implants across 59 partial rehabilitations, with 62 implants placed in the maxilla and 67 in the mandible. All interventions were performed by a single experienced operator using dental-supported stereolithographic guides and a flapless protocol. The discrepancy between planned and actual implant positions was measured using reverse engineering software, assessing linear deviations at the implant Platform (coronal) and apex, as well as angular deviations. Subgroup analyses were conducted based on the jaw (maxilla vs. mandible) and the type of surgical guide support (Kennedy classes I–IV). Results: The mean linear deviation was 1.16 ± 0.58 mm at the apex and 0.80 ± 0.41 mm at the implant Platform (coronal). The mean angular deviation was 3.23° ± 1.86°. Slightly higher deviations were observed in the mandible than in the maxilla. Group-wise analysis showed minor variations depending on the type of guide support. Conclusions: Static computer-guided surgery demonstrated measurable linear and angular deviations between planned and achieved implant positions. These discrepancies should be considered during treatment planning, especially in narrow ridges or Class I configurations.